Financial Frameworks That Empower Physicians:
Understanding the Compensation Conundrum in Healthcare ...

Saturday and Sunday – CLOSED
support@nationalmedicalfunding.com



Healthcare M&A financing is really three funding problems that rarely share one solution: the purchase price, the cost of getting the deal done, and the cash you need after closing. Most buyers combine their own equity with an SBA 7(a) or bank loan for the purchase, sometimes add a seller note, and arrange separate working capital for diligence and integration. This guide explains how each piece works, what lenders look at, and which healthcare-specific steps can quietly drain cash after the paperwork is signed.
Independent ownership has been shrinking for more than a decade. The American Medical Association’s Physician Practice Benchmark Survey reports that the share of physicians working in private practices fell from 60.1% in 2012 to 42.2% in 2024. When the AMA examined why private practices are sold to hospitals, private equity firms, or insurers, it found that inadequate payment rates, costly resources, and burdensome regulatory and administrative requirements are longstanding drivers.
Those pressures show up on both sides of a transaction. Sellers want an exit, or relief from administrative overhead. Buyers might be a physician stepping into ownership, a growing group adding a location, or a partner buying out a retiring colleague, and they are usually hoping for scale, patient volume, or a stronger position with payers. Whatever the motive, someone has to finance the deal, and the structure they choose will shape cash flow for years.
A useful way to plan is to split the money into three buckets, because each one has a different timeline and a different useful life.
The purchase price or buy-in. This is the largest number and the longest-lived commitment. It usually covers goodwill, equipment, and the patient base, and it is repaid over many years.
Transaction costs. Valuation, legal fees, accounting and tax review, billing and compliance review, lender fees, and any regulatory notices all arrive before closing. They are often paid whether or not the deal ultimately closes, which is why they deserve their own line in the budget.
Post-closing needs. Billing and payer enrollment rarely settle on day one, so working capital matters. Systems also need to be merged, equipment may need replacing, and staff need training and clear communication.
Keeping these separate avoids a common trap: matching the wrong repayment schedule to the wrong need. A short repayment window on a long-term asset puts pressure on cash flow exactly when a newly combined practice is hardest to forecast. Longer-term debt for long-lived assets, and shorter-term funding for short-lived needs, is the safer starting principle.
There are four main routes. Most real deals blend at least two of them. The comparison below shows how they differ at a glance, and the sections after it go deeper.
Funding source | Commonly used for | Main trade-off | Ask your lender |
|---|---|---|---|
SBA 7(a) loan | Full acquisitions, buy-ins, partner buyouts | More documentation and a longer timeline | What equity injection is required, and how is it verified? |
Conventional bank loan | Well-capitalized buyers with strong credit | Often a larger down payment and stronger collateral expectations | Will you finance goodwill, and at what loan-to-value? |
Seller financing | Bridging the gap between price and borrowing capacity | Depends on the seller’s willingness and clean documentation | Does the note count toward required equity under your program? |
Term loan, equipment financing, or working capital | Integration, equipment, and transition cash flow | Payment size relative to cash flow | How do payments fit our post-closing revenue? |
SBA 7(a) loans are a common route for buying an existing practice or buying out a partner. They are also the area where rules have changed most recently, so older articles can mislead you.
The SBA issued a new lending rulebook, SOP 50 10 8.1, on August 14, 2026, and its information notice lists an effective date of October 1, 2026. The edition it replaced, SOP 50 10 8, took effect in June 2025. According to a law firm summary of that earlier edition, buyers in a change of ownership need at least a 10 percent equity injection, and a seller note counts toward that injection only if it stays on full standby (no principal or interest payments) for the entire loan term and covers no more than half of the required amount.
Because the newer SOP reorganizes how changes of ownership are handled, confirm the current treatment with an SBA lender before building a deal around any specific structure. In particular, be skeptical of any source that describes zero-down acquisitions or seller notes that fully replace a down payment. You can read the primary document on the SBA’s SOP 50 10 page. If real estate is part of the transaction, our comparison of SBA 504 and 7(a) loans for medical practices explains how the two programs differ.
Banks that regularly lend to medical and dental practices can be a strong option for established buyers. They often ask for a larger down payment and stronger collateral or credit than SBA programs, but they can sometimes move faster once a buyer is qualified. If you have significant personal capital, a bank loan or a bank loan paired with a smaller SBA loan is worth pricing.
In seller financing, the owner agrees to be paid part of the price over time. It can bridge the gap between what a buyer can borrow and what the practice costs, and it keeps the seller invested in a smooth transition. The risks are practical ones: vague repayment terms, disagreements over how the practice performs after closing, and program rules that limit how much a seller note can count toward your required equity. A seller who keeps an ownership stake may also be required to provide a personal guarantee under the SBA rules summarized above. Put every term in writing, and have an attorney review it.
Shorter-term products are most useful for the costs that surround a deal: upgrading imaging or clinical equipment, funding technology changes, and covering the weeks when revenue is in transition. Some buyers also use them to fill part of a funding gap. Whether that makes sense depends on how the payment compares with the practice’s cash flow once the deal closes. You can see the range of options on the National Medical Funding products page, and the overview of healthcare loans explains how these products are structured for medical practices.

These numbers are hypothetical and chosen only to show the arithmetic.
Suppose the total project cost for a complete change of ownership is $1,000,000. That figure is not just the price on the letter of intent: SBA guidance defines project cost as all costs required to complete the change of ownership, so legal, valuation, and similar closing costs belong in the calculation.
A lender may ask for more than the minimum if the practice is heavily goodwill-based, has a short operating history, or if the buyer has limited experience in the specialty. Build your cash plan around the lender’s number, not the lowest number in an article.
Whether a lender is an SBA specialist or a community bank, they are ultimately financing a business, a license, and a transition at the same time. Expect scrutiny in several areas.
Valuation. If the price runs ahead of what the practice’s cash flow can support, the deal tends to stall. An independent valuation helps both sides anchor to a defensible number.
Quality of earnings. Many smaller practices keep their books on a cash basis, and owners often run personal or discretionary expenses through the business. A financial review that normalizes those items shows what the practice earns under new ownership.
Payer mix and contract terms. Reimbursement stability, concentration in a few payers, and the age of receivables all affect how reliably the practice can service debt.
Coding and billing practices. Lenders and buyers both want to know whether billing aligns with industry standards, because problems discovered later become the new owner’s problems.
Key people. If the selling physician stays on for a period, the terms of that arrangement matter. So does the likelihood that other providers and staff will remain.
Preparing helps. Gather several years of financial statements and tax returns, payer contracts, a current accounts receivable aging report, a list of providers and their credentials, and your own personal financial statement. Lenders commonly request items like these, and having them ready shortens the back-and-forth.
Due diligence is where deals are won or lost, and it is also where buyers are tempted to economize. The most useful way to think about it is as a cost of avoiding a larger one. An issue you find before closing is a negotiating point. The same issue found afterward is your expense.
A thorough review usually spans several workstreams:
Many buyers engage third-party advisors for the financial work, particularly when a practice has complicated books. Get written quotes from advisors before you sign a letter of intent, and ask whether any of those costs can be rolled into your financing plan. Because diligence spending is front-loaded and not guaranteed to lead to a closing, many buyers fund it with cash on hand or short-term working capital rather than the acquisition loan.

Healthcare transactions carry obligations that other small business purchases do not. Several of them influence timing and cash flow, so they belong in your financing plan.
Medicare enrollment. A change of ownership has to be reported to Medicare. According to one Medicare contractor’s enrollment guidance, physicians and groups must report a change of ownership within 30 days, and an unreported change can lead to revocation of billing privileges for one to three years. Check the process for your own Medicare contractor and assign someone to own it from the first week.
Payer contracts and credentialing. Depending on how a deal is structured, payer contracts may need to be assigned or renegotiated and providers may need to be re-credentialed. Timelines vary by payer, so ask each major payer early and build a cash buffer for the gap.
State transaction notice laws. A growing number of states require advance notice of certain healthcare transactions, and some reach small groups. Rhode Island, for example, published a notice form for medical-practice group transactions for use beginning January 28, 2026. For a broader view, a law firm maintains a multi-state tracker of healthcare pre-transaction notices. These laws change frequently, so confirm current requirements with healthcare counsel.
Federal premerger review. The federal Hart-Scott-Rodino filing threshold for 2026 is $133.9 million, a size a single-practice deal is unlikely to reach. State notice rules are a separate question and can apply at far lower deal sizes.
Structure review. Healthcare counsel should also review the deal for physician self-referral and anti-kickback considerations, and for state rules on who may own a medical practice. Those questions affect how the deal can be financed, not only how it can be signed.
After closing, the work shifts to making two operations function as one. The costs that most often catch owners off guard include merging or migrating EHR systems, aligning coding and billing workflows, strengthening cybersecurity for the combined data, retraining front-office and clinical staff, and communicating changes to patients.
Treat these as a separate budget from the purchase. Equipment and technology with a multi-year useful life can reasonably be financed over a matching term. Recurring or discretionary costs are different. Borrowing to fund retention bonuses or cosmetic upgrades is a business judgment worth testing against projected cash flow, since the debt outlasts the benefit if it is not tied to something that grows revenue or reduces cost.
People matter here too. Staff who hear about a merger through rumor tend to leave, so a clear communication plan from the start is cheaper than replacing providers or front-office team members later.
Before you commit to a lender, ask:
A good partner can answer these plainly, including the ones that point away from their own products.
Usually not with an SBA loan. A law firm summary of SBA’s SOP 50 10 8 says complete changes of ownership require at least a 10 percent buyer equity injection. Limited exceptions have been described for certain partner buyouts and partial changes of ownership, and lenders can require more. Confirm the current rule and your lender’s requirements before assuming any structure.
Sometimes, but only partly. Under SOP 50 10 8 as summarized by counsel, a seller note counts toward the equity injection only if it is on full standby for the entire loan term, and it cannot exceed 50 percent of the required injection. A note that requires payments from the start does not qualify. Ask your lender how the newer SOP 50 10 8.1 treats it.
It depends on the lender, the loan type, and how organized your documents are. SBA-backed loans generally involve more documentation and a longer timeline than conventional loans. Ask each lender for a written timeline by stage, and start diligence and financing conversations in parallel so neither one holds up the other.
Many lenders want independent verification, particularly when books are on a cash basis or owner expenses are mixed with business expenses. Recent SBA rule changes reportedly increase third-party valuation and verification expectations for acquisitions, though sources differ on the details. Ask your lender which reports it requires, and who may order them, before you pay for any.
Federal premerger filings apply only above size thresholds, and the 2026 base threshold is $133.9 million, which most single-practice deals will not reach. State notice laws are a separate issue. Some states require advance notice of certain healthcare transactions, so check state requirements with healthcare counsel before you sign.
The change must be reported to Medicare, and one contractor’s guidance says to do so within 30 days of the change taking effect. Missing that deadline can lead to revocation of billing privileges. Your cash plan should also account for payer credentialing and contract timelines, which vary by payer.
It can help with the surrounding costs, such as diligence, equipment, and transition cash flow, and some buyers use it to fill part of a gap. Carrying the entire purchase on short repayment terms is harder, because the payments may be large relative to cash flow. Test any structure against conservative projections before you accept it.
Possibly, but SBA ownership and citizenship requirements were tightened in recent rule updates, and sources differ on the details of the newest edition. Ask an SBA lender about your specific situation before you invest in diligence.
Strong healthcare M&A financing starts with separating the purchase from the surrounding costs, matching each piece of funding to how long it will be needed, and building in time for the regulatory and enrollment steps unique to medical practices. The buyers who avoid surprises are usually the ones who talk to lenders early, verify current SBA rules, and budget for diligence and integration as real line items.
If you are weighing options, start with the loan calculator to test payments against your projections, then apply or request a conversation with the National Medical Funding team to talk through how your deal could be structured. Your attorney, accountant, and lender should confirm the specifics for your situation.
Understanding the Compensation Conundrum in Healthcare ...
When Innovation Meets Income Running a healthcare...